| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM401411Z |
| P698 | PubMed publication ID | 24151987 |
| P50 | author | Jürgen Bajorath | Q18609784 |
| Dagmar Stumpfe | Q65088036 | ||
| Martin Vogt | Q71033158 | ||
| P2093 | author name string | Gerald Maggiora | |
| P2860 | cites work | Chemical Similarity Searching | Q28090770 |
| Analysis of a large structure/biological activity data set using recursive partitioning | Q30585909 | ||
| Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition | Q30812889 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3186-3204 | |
| P577 | publication date | 2013-11-11 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Molecular similarity in medicinal chemistry. | |
| P478 | volume | 57 |
| Q41018716 | 3D Chemical Similarity Networks for Structure-Based Target Prediction and Scaffold Hopping |
| Q41861993 | A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs |
| Q90790499 | A Quantum-Inspired Method for Three-Dimensional Ligand-Based Virtual Screening |
| Q28830529 | A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors |
| Q45946583 | A Simple Representation of Three-Dimensional Molecular Structure. |
| Q90038595 | A big data approach with artificial neural network and molecular similarity for chemical data mining and endocrine disruption prediction |
| Q50616685 | A pose prediction approach based on ligand 3D shape similarity |
| Q38827863 | A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer. |
| Q94109024 | A visual approach for analysis and inference of molecular activity spaces |
| Q92815801 | Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search |
| Q38243627 | Activity cliff networks for medicinal chemistry |
| Q40123032 | Activity-relevant similarity values for fingerprints and implications for similarity searching |
| Q38918857 | Advances in Activity Cliff Research |
| Q54156199 | Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR. |
| Q35838408 | An overview of molecular fingerprint similarity search in virtual screening |
| Q47424759 | Analysing and Navigating Natural Products Space for Generating Small, Diverse, But Representative Chemical Libraries |
| Q64963243 | Analysis and Comparison of Vector Space and Metric Space Representations in QSAR Modeling. |
| Q41959283 | Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures |
| Q60238445 | Application of a New Scaffold Concept for Computational Target Deconvolution of Chemical Cancer Cell Line Screens |
| Q90194262 | Application of the SwissDrugDesign Online Resources in Virtual Screening |
| Q36227748 | Applications of Systematic Molecular Scaffold Enumeration to Enrich Structure-Activity Relationship Information |
| Q100946063 | Automatic construction of molecular similarity networks for visual graph mining in chemical space of bioactive peptides: an unsupervised learning approach |
| Q41093798 | Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening |
| Q39184031 | Bioisosteres and Scaffold Hopping in Medicinal Chemistry |
| Q38944860 | Cellular manganese content is developmentally regulated in human dopaminergic neurons |
| Q114873664 | Chemical similarity methods for analyzing secondary metabolite structures |
| Q38918346 | Chemoinformatics at the University of Sheffield 2002-2014. |
| Q47200709 | Chemoinformatics: a perspective from an academic setting in Latin America. |
| Q55669325 | Combining Similarity Searching and Network Analysis for the Identification of Active Compounds. |
| Q38366350 | Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery |
| Q42840256 | Comparative analysis of chemical similarity methods for modular natural products with a hypothetical structure enumeration algorithm |
| Q27902270 | Comparing structural fingerprints using a literature-based similarity benchmark |
| Q85323813 | Comparison of bioactive chemical space networks generated using substructure- and fingerprint-based measures of molecular similarity |
| Q36206434 | Compound Data Mining for Drug Discovery |
| Q60238441 | Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors |
| Q38452129 | Compound annotation with real time cellular activity profiles to improve drug discovery |
| Q36156312 | Comprehensive prediction of drug-protein interactions and side effects for the human proteome |
| Q59790563 | Computational Assessment of Chemical Saturation of Analogue Series under Varying Conditions |
| Q37414273 | Computational Drug Target Screening through Protein Interaction Profiles |
| Q88406300 | Computational Prediction and Analysis of Associations between Small Molecules and Binding-Associated S-Nitrosylation Sites |
| Q27902263 | Computational methods for prediction of in vitro effects of new chemical structures |
| Q38686087 | Computational scaffold hopping: cornerstone for the future of drug design? |
| Q38530502 | Computer-aided drug discovery |
| Q36066303 | Connecting proteins with drug-like compounds: Open source drug discovery workflows with BindingDB and KNIME. |
| Q94595614 | Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer |
| Q39035004 | Context-sensitive network-based disease genetics prediction and its implications in drug discovery |
| Q48359343 | Cross-Classified Multilevel Modelling of the Effectiveness of Similarity-Based Virtual Screening |
| Q90633197 | Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches |
| Q30873834 | Design and characterization of chemical space networks for different compound data sets |
| Q48230088 | Design of a tripartite network for the prediction of drug targets |
| Q35875854 | Design of chemical space networks on the basis of Tversky similarity |
| Q86320243 | Design of chemical space networks using a Tanimoto similarity variant based upon maximum common substructures |
| Q90619385 | Development and Testing of Druglike Screening Libraries |
| Q64970469 | Development of a protein-ligand extended connectivity (PLEC) fingerprint and its application for binding affinity predictions. |
| Q48238825 | Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches |
| Q55713185 | Distributed Representation of Chemical Fragments. |
| Q33802239 | Drug repositioning for enzyme modulator based on human metabolite-likeness |
| Q36342657 | Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine |
| Q102331504 | Evaluating chemical similarity as a measure to identify potential substances of very high concern |
| Q97567676 | Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening |
| Q48035411 | Exploring sets of molecules from patents and relationships to other active compounds in chemical space networks |
| Q35214824 | Hierarchical virtual screening approaches in small molecule drug discovery |
| Q24273350 | How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion |
| Q40816292 | Identification of Interaction Hot Spots in Structures of Drug Targets on the Basis of Three-Dimensional Activity Cliff Information |
| Q41612781 | Identification of novel small molecule Beclin 1 mimetics activating autophagy |
| Q93362283 | Implicit-descriptor ligand-based virtual screening by means of collaborative filtering |
| Q58576156 | Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective |
| Q36223164 | Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer |
| Q41504204 | Introducing the 'active search' method for iterative virtual screening |
| Q38766062 | Investigating the organic and conventional production type of olive oil with target and suspect screening by LC-QTOF-MS, a novel semi-quantification method using chemical similarity and advanced chemometrics |
| Q28545239 | Large-scale chemical similarity networks for target profiling of compounds identified in cell-based chemical screens |
| Q27902320 | Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations |
| Q91942928 | Ligand biological activity predicted by cleaning positive and negative chemical correlations |
| Q35810554 | Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells |
| Q55362065 | Linguistic measures of chemical diversity and the "keywords" of molecular collections. |
| Q90425483 | Linking synthesis and structure descriptors from a large collection of synthetic records of zeolite materials |
| Q36305094 | MOST: most-similar ligand based approach to target prediction. |
| Q115926304 | Maximum common property: a new approach for molecular similarity |
| Q50596276 | Maximum common substructure-based Tversky index: an asymmetric hybrid similarity measure |
| Q30885132 | Maximum common substructure-based data fusion in similarity searching |
| Q38865504 | Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. |
| Q28597594 | MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites |
| Q91809228 | Mimicking Strategy for Protein-Protein Interaction Inhibitor Discovery by Virtual Screening |
| Q93126855 | Molecular Docking: Shifting Paradigms in Drug Discovery |
| Q93369470 | Molecular fingerprint-derived similarity measures for toxicological read-across: Recommendations for optimal use |
| Q48913232 | Multi-Layer Identification of Highly-Potent ABCA1 Up-Regulators Targeting LXRβ Using Multiple QSAR Modeling, Structural Similarity Analysis, and Molecular Docking. |
| Q56797553 | Multivariate statistical analysis of a large odorants database aimed at revealing similarities and links between odorants and odors |
| Q37312034 | Olive Oil-derived Oleocanthal as Potent Inhibitor of Mammalian Target of Rapamycin: Biological Evaluation and Molecular Modeling Studies |
| Q58767948 | Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets |
| Q50089879 | Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening |
| Q35549038 | Panoramic view of a superfamily of phosphatases through substrate profiling |
| Q62741716 | Predicting electronic structure properties of transition metal complexes with neural networks |
| Q37473901 | Predicting protein-ligand affinity with a random matrix framework |
| Q39474699 | Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes |
| Q36092809 | Prospective evaluation of shape similarity based pose prediction method in D3R Grand Challenge 2015. |
| Q28222668 | QSAR modeling: where have you been? Where are you going to? |
| Q94477921 | QSAR without borders |
| Q90257724 | Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A Mimetics |
| Q61630497 | Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics |
| Q52667713 | Spectrophores as one-dimensional descriptors calculated from three-dimensional atomic properties: applications ranging from scaffold hopping to multi-target virtual screening. |
| Q41580357 | Structural and Functional View of Polypharmacology. |
| Q47202968 | Structure activity relationship (SAR) toxicological assessments: The role of expert judgment |
| Q64996405 | Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells. |
| Q94464127 | TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology |
| Q27902317 | Target prediction utilising negative bioactivity data covering large chemical space |
| Q64067149 | TeachOpenCADD: a teaching platform for computer-aided drug design using open source packages and data |
| Q64076270 | The Light and Dark Sides of Virtual Screening: What Is There to Know? |
| Q40813619 | The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor |
| Q24188395 | The eNanoMapper database for nanomaterial safety information |
| Q38856712 | The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions |
| Q38256258 | Tools for in silico target fishing |
| Q38944440 | Toward a unifying strategy for the structure-based prediction of toxicological endpoints |
| Q40605856 | Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites |
| Q42278847 | VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. |
| Q27702310 | Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? |
| Q96222884 | cando.py: Open source software for predictive bioanalytics of large scale drug-protein-disease data |
Search more.